Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PE859 is a potent inhibitor of both tau and Aβ aggregation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 119.00 | |
2 mg | In stock | $ 168.00 | |
5 mg | In stock | $ 255.00 | |
10 mg | In stock | $ 389.00 | |
25 mg | In stock | $ 652.00 | |
50 mg | In stock | $ 928.00 | |
100 mg | In stock | $ 1,260.00 | |
500 mg | In stock | $ 2,530.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 279.00 |
Description | PE859 is a potent inhibitor of both tau and Aβ aggregation. |
Targets&IC50 | Aβ:1.2 μM, tau:0.66 μM |
In vitro | In an Alzheimer's patient's brain, senile plaques and neurofibrillary tangles, the abnormal aggregates of amyloid β (Aβ) peptide and Tau Protein, are observed as the two major hallmarks of this disease. PE859 inhibits the heparin-induced aggregation of both 3RMBD and full length tau in a concentration-dependent manner. In each assay, the IC50 values calculated at the last measurement periods are 0.81 μM, and 2.23 μM, respectively. PE859 inhibits tau aggregation through the formation of a beta-sheet structure[2]. |
In vivo | PE859 is able to cross the blood-brain barrier and thus PE859 could be distributed into the tissues of the central nervous system. The maximum concentration of PE859 is 2.005 μg/mL in the blood at 3 h and 1.428 μg/g in the brain at 6 h. PE859 delays onset and progression of the motor dysfunction in JNPL3 mice. PE859 delays progression of the motor dysfunction through the inhibition of accumulation of sarkosyl-insoluble tau. [2] |
Kinase Assay | PEL cells are incubated in triplicate in a 96-well microculture plate in the presence of different concentrations of methyl-β-cyclodextrin (0-10 mM) in a final volume of 0.1 mL for 24 h at 37°C. Subsequently, MTT (0.5 mg/mL final concentration) is added to each well. After 3 h of additional incubation, 100 μL of a 0.04 N HCl is added to dissolve the crystals. Absorption values at 570 nm are determined. |
Molecular Weight | 448.52 |
Formula | C28H24N4O2 |
CAS No. | 1402727-29-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PE859 1402727-29-0 Cytoskeletal Signaling Neuroscience Proteases/Proteasome Stem Cells Beta Amyloid Gamma-secretase Microtubule Associated PE 859 Inhibitor PE-859 inhibit Microtubule/Tubulin inhibitor